Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-03-30

Clinical Trial Update: Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel [NA]

View source ↗

Summary

A completed clinical trial comparing 0.3% adapalene gel to Differin 0.3% adapalene gel for acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adapalene Topical Gel (adapalene)
  • DIFFERIN (ADAPALENE)

Snippet

Sponsor: Actavis Mid-Atlantic LLC | Conditions: Acne Vulgaris | NA | Status: COMPLETED